SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-069625
Filing Date
2024-06-07
Accepted
2024-06-07 16:05:20
Documents
14
Period of Report
2024-06-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416682d1_8k.htm   iXBRL 8-K 43046
2 EXHIBIT 3.1 tm2416682d1_ex3-1.htm EX-3.1 7986
  Complete submission text file 0001104659-24-069625.txt   230795

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20240604.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20240604_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20240604_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416682d1_8k_htm.xml XML 3801
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 241029292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)